Editorial comment. Is there enough evidence that proves clinical equipoise between stenting and coronary surgery for patients with left main coronary artery disease?

European Journal of Cardio-thoracic Surgery

Volumn 38, Issue 4, 2010, Pages 428-430

  Kappetein, Arie Pieter ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Angioplasty; Coronary artery bypass surgery; Coronary artery disease

Indexed keywords

BOLDENONE UNDECENOATE; EVEROLIMUS;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; FOLLOW UP; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NOTE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; SCORING SYSTEM; STROKE;

ANGIOPLASTY, BALLOON, CORONARY; CORONARY ARTERY BYPASS; CORONARY DISEASE; EVIDENCE-BASED MEDICINE; HUMANS; STENTS; THERAPEUTIC EQUIPOISE;

EID: 77957251829     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2010.04.014     Document Type: Note

References (11)

1. Chikwe J., Kim M., Goldstone A.B., Fallahi A., Athanasiou T. Current diagnosis and management of left main coronary disease. Eur J Cardiothorac Surg 2010, 38:420-428.
2. Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Survival data. Circulation 1983, 68:939-950.
3. Patel M.R., Dehmer G.J., Hirshfeld J.W., Smith P.K., Spertus J.A. ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: a report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol 2009, 53:530-553.
4. Seung K.B., Park D.-W., Kim Y.-H., Lee S.-W., Lee C.W., Hong M.-K., Park S.-W., Yun S.-C., Gwon H.-C., Jeong M.-H., Jang Y., Kim H.-S., Kim P.J., Seong I.-W., Park H.S., Ahn T., Chae I.-H., Tahk S.-J., Chung W.-S., Park S.-J. Stents versus coronary-artery bypass grafting for left main coronary artery disease. N Engl J Med 2008, 358:1781-1792.
5. Chieffo A., Morici N., Maisano F., Bonizzoni E., Cosgrave J., Montorfano M., Airoldi F., Carlino M., Michev I., Melzi G., Sangiorgi G., Alfieri O., Colombo A. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience. Circulation 2006, 113:2542-2547.
6. Kappetein A.P., Dawkins K.D., Mohr F.W., Morice M.C., Mack M.J., Russell M.E., Pomar J., Serruys P.W.J.C. Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. Insights from the SYNTAX run-in phase. Eur J Cardiothorac Surg 2006, 29:486-491.
7. Serruys P.W., Morice M.-C., Kappetein A.P., Colombo A., Holmes D.R., Mack M.J., Ståhle E., Feldman T.E., van Den Brand M., Bass E.J., Van Dyck N., Leadley K., Dawkins K.D., Mohr F.W. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009, 360:961-972.
8. Sianos G., Morel M.-A., Kappetein A.P., Morice M.-C., Colombo A., Dawkins K., van Den Brand M., Van Dyck N., Russell M.E., Mohr F.W., Serruys P.W. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005, 1:219-227.
9. Smith C.R. Surgery, not percutaneous revascularization, is the preferred strategy for patients with significant left main coronary stenosis. Circulation 2009, 119:1013-1020.
10. Stone G.W., Midei M., Newman W., Sanz M., Hermiller J.B., Williams J., Farhat N., Mahaffey K.W., Cutlip D.E., Fitzgerald P.J., Sood P., Su X., Lansky A.J. Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial. J Am Med Assoc 2008, 299:1903-1913.
11. DeMets D.L., Califf R.M. Lessons learned from recent cardiovascular clinical trials: Part I. Circulation 2002, 106:746-751.